NGGT001

· NGGT (Suzhou) Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NGGT001, covering 2025-05-25 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy Subjects [Phase 1, Phase 2]